- Record: found
- Abstract: not found
- Article: not found
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
Sana M Al-Khatib ,
William G Stevenson
1 ,
Michael J Ackerman
1 ,
William J Bryant
1 ,
David J Callans
1 ,
Anne B Curtis
1 ,
Barbara J Deal
1 ,
Timm Dickfeld
1 ,
Michael E Field
1 ,
Gregg C Fonarow
1 ,
Anne M Gillis
1 ,
Christopher B Granger
1 ,
Stephen C Hammill
1 ,
Mark A Hlatky
1 ,
José A Joglar
1 ,
G Neal Kay
1 ,
Daniel D Matlock
1 ,
Robert J Myerburg
1 ,
Richard L Page
1
September 25 2018
AHA Scientific Statements,
CT imaging,
ECG,
MR imaging,
acute coronary syndrome,
ambulatory ECG monitoring,
antiarrhythmic drug therapy,
arrhythmogenic cardiomyopathy,
athletes,
cardiac electrophysiology,
cardiac resynchronization therapy,
cardiomyopathy,
catheter ablation,
congenital heart disease,
echocardiography,
electrophysiological testing,
genetic arrhythmias,
guidelines,
heart failure,
imaging,
implantable and external cardioverter devices,
implantable cardioverter-defibrillator,
medication-induced arrhythmias,
myocardial infarction,
premature ventricular beats,
resuscitation,
sarcoidosis,
specific pathology (eg, congenital heart disease, myocarditis, renal failure),
stable coronary artery disease,
sudden cardiac arrest,
sudden cardiac death,
torsades de pointes,
ventricular fibrillation,
ventricular tachycardia
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Author and article information
AHA Scientific Statements,CT imaging,ECG,MR imaging,acute coronary syndrome,ambulatory ECG monitoring,antiarrhythmic drug therapy,arrhythmogenic cardiomyopathy,athletes,cardiac electrophysiology,cardiac resynchronization therapy,cardiomyopathy,catheter ablation,congenital heart disease,echocardiography,electrophysiological testing,genetic arrhythmias,guidelines,heart failure,imaging,implantable and external cardioverter devices,implantable cardioverter-defibrillator,medication-induced arrhythmias,myocardial infarction,premature ventricular beats,resuscitation,sarcoidosis,specific pathology (eg, congenital heart disease, myocarditis, renal failure),stable coronary artery disease,sudden cardiac arrest,sudden cardiac death,torsades de pointes,ventricular fibrillation,ventricular tachycardia
AHA Scientific Statements, CT imaging, ECG, MR imaging, acute coronary syndrome, ambulatory ECG monitoring, antiarrhythmic drug therapy, arrhythmogenic cardiomyopathy, athletes, cardiac electrophysiology, cardiac resynchronization therapy, cardiomyopathy, catheter ablation, congenital heart disease, echocardiography, electrophysiological testing, genetic arrhythmias, guidelines, heart failure, imaging, implantable and external cardioverter devices, implantable cardioverter-defibrillator, medication-induced arrhythmias, myocardial infarction, premature ventricular beats, resuscitation, sarcoidosis, specific pathology (eg, congenital heart disease, myocarditis, renal failure), stable coronary artery disease, sudden cardiac arrest, sudden cardiac death, torsades de pointes, ventricular fibrillation, ventricular tachycardia